Introduction
The increase in numbers of isolates of Staphylococcus aureus resistant to methicillin (MRSA) has had a major impact on antibiotic prescribing practices and infection control policies in hospitals. Reporting of blood culture and cerebrospinal fluid (CSF) isolates to the Public Health Laboratory Service Communicable Disease Surveillance Centre (PHLS CDSC), showed that there was an increase in the proportion represented by MRSA in England and Wales, from 1.5% of all S. aureus isolates in 1989-1991 to 13.2% in 1995, 1 and that 32% of S. aureus bloodstream infections in 1997 were caused by MRSA. 2 In Wales, blood culture and CSF surveillance data have been gathered electronically since 1993. In addition, enhanced surveillance of all MRSA isolates from any site has been carried out since 1996. These two schemes have permitted changes in antibiotic resistance rates to be documented from 1993 to 1997.
Materials and methods
Surveillance is based on the results of routine microbiology testing in Wales, as reported to CDSC. Reports of isolates from blood cultures and CSF specimens and all new MRSA isolations are collected via CoSurv, a set of interconnected electronic database modules for communicable disease control. 3 Data are transmitted to CDSC Wales for allWales analysis. Some under-reporting will have occurred over the surveillance period. The Mantel-Haenszel 2 test was used for comparison of proportions, and trends were analysed using 2 for trends. The Wilcoxon rank-sum test was used for the comparison of ages. Mid 1996 and 1997 population estimates 4, 5 were used as denominators for the calculation of rates for the total population surveyed.
Results
The total number of organisms reported from blood cultures and CSF almost doubled (91% increase, 2059 to 3924) between 1993 and 1997 ( (Table II) . Not all laboratories in Wales reported a high percentage of MRSA. The percentage resistant in 1997 ranged from a minimum of 0% to a maximum of 100%, although both laboratories reporting these extremes reported very small numbers. The median percentage reported was 37.5% and more than half the laboratories reported a resistance rate of 20%.
Comparison of patients with MRSA and MSSA isolated from blood cultures and CSF is shown in Surveillance of all MRSA isolates in Wales from any clinical site in 1996 and 1997 showed that the reporting rate doubled (92.43/100 000 population in 1996; 177.76/100 000 in 1997). The proportion of isolates from blood culture and CSF specimens remained constant at 5.6% (1996, 152/2700; 1997, 292/5203).
Discussion
Since 1993, there has been an increase, both in absolute numbers and as a proportion of all isolates of S. aureus from blood and CSF. This can be attributed to the rising incidence of MRSA infections, since although the numbers of isolates of MSSA have increased, as a proportion of the total, the percentage has fallen. MRSA has both displaced MSSA as a causal organism and has been responsible for an excess number of infections.
It is possible that the higher numbers of MRSA reported from blood cultures and CSF in recent years occurred as a result of an increase in virulence of MRSA strains. This would cause more cases of serious illness, which would be reflected in the numbers reported from blood cultures and CSF specimens. The data from the total population surveillance do not support this hypothesis. Although the total number of blood cultures and CSF from which MRSA was isolated doubled between 1996 and 1997, the overall number of reports of MRSA from any site also doubled.
The proportion of MRSA isolated from blood cultures and CSF, therefore, remained constant. The data indicate that a general increase in the incidence and prevalence of MRSA led in turn to more cases of serious illness attributable to both MRSA and all strains of S. aureus.
Data showed that the overall percentage of methicillin resistance in S. aureus from blood cultures and CSF in Wales in 1997 was 43%, but there was quite considerable variation between trusts. Combined data for England and Wales are only available up to 1995 for blood cultures and CSF, which showed the percentage of resistance to be 13%. 1 Methicillin resistance of S. aureus in blood cultures and CSF in Wales in 1995 was 17%, higher than the national average. Examination of the England and Wales data for 1995 by region, showed that certain regions (particularly Thames regions) already had resistance rates of over 20%. 1 It is not known whether resistance rates have continued to rise in these areas. Data on reported S. aureus bloodstream infections in England and Wales in 1997 showed that the proportion of methicillin resistance was 32% and that the spread was more evenly distributed across the country than reported previously. 2 Only 13 isolates of S. aureus were reported from CSF in Wales between 1993 and 1997, with four reported in 1997, therefore data can be considered generally equivalent. It is possible that enhanced surveillance of MRSA in Wales from 1996 onwards has meant that laboratories in Wales are more likely to report an MRSA bacteraemia than an MSSA bacteraemia, resulting in an inflated rate of resistance compared with previous years and other regions.
Analysis of data in Wales by age and gender showed that, although there was variation in age-and genderspecific rates of methicillin resistance in S. aureus isolates from blood culture and CSF, the proportion of resistant strains was substantial in all groups with the exception of female patients under 15 years of age. The proportion of resistant strains in elderly men in 1997 was of particular concern. It may be that the empirical use of flucloxacillin or a cephalosporin 6 is no longer appropriate in certain age/ gender groups if serious staphylococcal sepsis is suspected. Since rates of methicillin resistance reported varies considerably between sites, analysis is required at a local level to determine the situation with regard to prescribing policies.
